Journal
AUTOPHAGY
Volume 3, Issue 6, Pages 581-585Publisher
LANDES BIOSCIENCE
DOI: 10.4161/auto.4782
Keywords
autophagy; coronavirus; macrophage; fibroblast; murine hepatitis virus
Categories
Funding
- NIAID NIH HHS [AI59443, U54 AI057160, AI50083] Funding Source: Medline
Ask authors/readers for more resources
Macroautophagy (herein autophagy) is a cellular process, requiring ATG5, by which cells deliver double membrane-bound packets containing cytoplasm or cytoplasmic organelles to the lysosome. This process has been reported in some cases to be antiviral, while in other cases it has been reported to be required for efficient viral replication or release. A role for autophagy in RNA virus replication has been an attractive hypothesis because of the association of RNA virus replication with complex membrane rearrangements in the cytoplasm that can generate opposed double membranes. In this study we demonstrate that ATG5 is not required for murine hepatitis virus (MHV) replication in either bone marrow derived macrophages (BMM phi) lacking ATG5 by virtue of Crerecombinase mediated gene deletion or primary low passage murine ATG5(-/-) embryonic fibroblasts (pMEFs). We conclude that neither ATG5 nor an intact autophagic pathway are required for MHV replication or release.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available